CardioDx Launches Gene Test For Obstructive Coronary Disease

CardioDx is gradually rolling out its Corus CAD gene expression test, which quantifies the likelihood of obstructive coronary artery disease in patients with stable chest pain and no previous history of cardiac disease

More from Archive

More from Medtech Insight